Glow 70mg: Research Applications

Research Applications

Laboratory studies using the GLOW combination — or the individual components in parallel — have explored:

1. Dermal Wound Healing & Re-Epithelialization — GHK-Cu (collagen/elastin synthesis), BPC-157 (granulation tissue formation), and TB-500/Tβ4 (keratinocyte migration) each independently accelerate full-thickness wound closure in rodent models.[11][17][18]
2. Tendon, Ligament & Skeletal Muscle Repair — BPC-157 has been shown to accelerate Achilles transection healing; TB-500 supports myoblast and tenocyte migration; GHK-Cu modulates MMP/TIMP balance for connective-tissue remodeling.[19][20]
3. Angiogenesis Models — BPC-157 (VEGFR2-driven) and TB-500/Tβ4 (epicardial progenitor mobilization) have both been documented to enlarge collateral vessel networks in ischemia paradigms.[5][21]
4. Dermatology & Hair Follicle Research — GHK-Cu enlarges follicle size and prolongs anagen phase in preclinical models; the actin-binding region of Tβ4 (the TB-500 fragment) has been identified as an active site for hair-growth signaling.[22][23]
5. Anti-Inflammatory & Antioxidant Models — All three components suppress NF-κB activation; GHK-Cu and TB-500 upregulate SOD/catalase; BPC-157 and TB-500 attenuate liver fibrosis in CCl₄/ethanol models.[24][25]
6. Corneal & Ocular Surface Repair — BPC-157 and the Tβ4-derived peptides have independently demonstrated accelerated corneal epithelial repair in preclinical studies.[26]

Important: every cited study above used individual peptides, not the GLOW combination. Researchers using the blend should design experiments accordingly and not assume that the sum of single-agent effects has been validated in combination.